Recombinant IL12B (Briakinumab Biosimilar) anticorps

N° du produit ABIN7795102

Cet anticorps anti-IL12B (Briakinumab Biosimilar) Monoclonal Souris (ABIN7795102) détecte spécifiquement IL12B (Briakinumab Biosimilar) dans FACS et in vivo. L’anticorps est réactif avec des échantillons de Humain.

Aperçu rapide pour Recombinant IL12B (Briakinumab Biosimilar) anticorps (ABIN7795102)

Antigène: IL12B (Briakinumab Biosimilar)

Type d'anticorp: Recombinant Antibody

Reactivité: Humain

Hôte: Souris

Clonalité: Monoclonal

Conjugué: Cet anticorp IL12B (Briakinumab Biosimilar) est non-conjugé

Application: Flow Cytometry (FACS), In vivo Studies (in vivo)

Classe de qualité: Research Grade

Détail du produit anti-IL12B (Briakinumab Biosimilar) anticorps

Expression System: Mammalian cells

Fonction: Briakinumab Biosimilar, IL-12 / IL-23 Monoclonal Antibody

Attributs du produit: What is Briakinumab Biosimilar research grade? Briakinumab is a human anti-IL-12 / IL-23 monoclonal antibody being developed for the treatment of a number of T-cell driven autoimmune diseases. It targets and neutralize interleukin-12 and interleukin-23, two proteins associated with inflammation, such as pro-inflammatory interleukins or tumor necrosis factor- alpha. Briakinumab represents a novel approach to treating psoriasis, Multiple Sclerosis, Crohn's Disease and other autoimmune and inflammatory disorders. Briakinumab Biosimilar uses the same protein sequences as the therapeutic antibody briakinumab.

Purification: Protein A or G affinity column

Pureté: >95 % by reducing SDS-PAGE

niveau d'endotoxine: < 1 EU per 1 mg of the protein by the LAL method

Immunogène: Human IL-12 / IL-23

Information d'application

Indications d'application: Optimal working dilution should be determined by the investigator.

Restrictions: For Research Use only

Stockage

Format: Liquid

Concentration: > 3 mg/mL

Stock: 4 °C,-20 °C

Stockage commentaire: Short time 2 to 8°C as supplied. Long time -20°C to -70°C as supplied.

Détails sur IL12B (Briakinumab Biosimilar)

Antigène: IL12B (Briakinumab Biosimilar)

Autre désignation: Briakinumab Biosimilar

Classe de substances: Biosimilar